The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research
How Ozempic And Wegovy Accidentally Made Novo Nordisk A $400B Company
How Novo Nordisk built an empire selling diabetes and weight-loss drugs
TIME100 Most Influential Companies: Novo Nordisk
Nordisk: Care & Repair
The Analytics-Powered Organisation - Martin Klavstrup Mathiasen, Novo Nordisk
Dr. Scot Gottlieb on Novo Nodrisk's oral diabetes drug, future of weight-loss drugs
Does Novo Nordisk already have the next Ozempic?
Novo Nordisk CEO on safety concerns associated with off-label use of diabetes drugs
Novo Nordisk (Ozempic)
With Novo Nordisk success, is there a "Nokia risk" for Denmark?
HCLS Symposium 2021: Novo Nordisk
ノボ ノルディスク CEO、製品価格について：当社の数字は「前年比で減少している」
New research aids Novo Nordisk and others spread out programs for recycling old products
Can Ozempic make America the sexiest country on the planet? | What's Next for Novo Nordisk?
The spirit of our founders: The values and mindsets that created Novo Nordisk a century ago
ノボ ノルディスクのマーケティング戦略
Novo Nordisk CEO on Wegovy, Ozempic Supplies and Pricing
Novo Nordisk CEO on treating diabetes and obesity, and challenges facing the industry
